Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma

INTRODUCTION: Multiple myeloma (MM) is a malignant hematological disease characterized by malignant proliferation of a single plasma cell clone leading to monoclonal protein in plasma or urine. Presence of monoallelic loss of chromosome 13 (del13) or loss of long arm (del13q) indicates poor prognost...

Full description

Bibliographic Details
Main Authors: Yusuf Coşkun, Güven Çetin, Mecdi Hikmet Ergüney
Format: Article
Language:English
Published: Van Yuzuncu Yil University, School of Medicine 2021-01-01
Series:Van Tıp Dergisi
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-27790
_version_ 1827608487640694784
author Yusuf Coşkun
Güven Çetin
Mecdi Hikmet Ergüney
author_facet Yusuf Coşkun
Güven Çetin
Mecdi Hikmet Ergüney
author_sort Yusuf Coşkun
collection DOAJ
description INTRODUCTION: Multiple myeloma (MM) is a malignant hematological disease characterized by malignant proliferation of a single plasma cell clone leading to monoclonal protein in plasma or urine. Presence of monoallelic loss of chromosome 13 (del13) or loss of long arm (del13q) indicates poor prognostic outcome in patients treated with standard chemotherapy. Del13/del13q is detected by FISH method in approximately half of newly diagnosed MM patients. METHODS: 42 patients diagnosed with MM according to the criteria of the International myeloma working group and treated at research and education hospital, were included in this study. Clinical, laboratory, pathological data were analyzed retrospectively and genetic data obtained by FISH method. RESULTS: 26 patients were female (61.9%) and 16 were male (38.1%). The mean age was 62. Del13 results were obtained in 30 of 42 patients, while positive in 6 patients (20%) negative in 24 patients (80%). Among the 30 patients with chromosome 13 results, 4 had IgA, 19 had IgG type monoclonal protein. All of the 6 patients with del13 were IgG myeloma (2 kappa, 3 lambda). DISCUSSION AND CONCLUSION: Compared to the recent studies, del13 is lower in our study. In many studies, del13 has been found in rates ranging from 30-50%. Although the rate of 20% we found is lower than the data in the literature, it is valuable in terms of reflecting the frequency of del13 in myeloma patients. Therefore, we strongly recommend that conventional karyotyping and FISH analysis of common chromosomal abnormalities be performed in newly diagnosed MM patients.
first_indexed 2024-03-09T07:13:47Z
format Article
id doaj.art-e5c04109ff0f4aaba9557bb5c162c3cf
institution Directory Open Access Journal
issn 2587-0351
language English
last_indexed 2024-03-09T07:13:47Z
publishDate 2021-01-01
publisher Van Yuzuncu Yil University, School of Medicine
record_format Article
series Van Tıp Dergisi
spelling doaj.art-e5c04109ff0f4aaba9557bb5c162c3cf2023-12-03T08:55:05ZengVan Yuzuncu Yil University, School of MedicineVan Tıp Dergisi2587-03512021-01-01281445010.5505/vtd.2021.27790VTD-27790Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myelomaYusuf Coşkun0Güven Çetin1Mecdi Hikmet Ergüney2Diskapı Yildirim Beyazit Training and Research Hospital, Department of Gastroenterology, AnkaraBezmialem Vakıf University Faculty of Medicine, Department of Hematology, IstanbulIstanbul Education and Research Hospital, Department of Internal Medicine, Istanbul,INTRODUCTION: Multiple myeloma (MM) is a malignant hematological disease characterized by malignant proliferation of a single plasma cell clone leading to monoclonal protein in plasma or urine. Presence of monoallelic loss of chromosome 13 (del13) or loss of long arm (del13q) indicates poor prognostic outcome in patients treated with standard chemotherapy. Del13/del13q is detected by FISH method in approximately half of newly diagnosed MM patients. METHODS: 42 patients diagnosed with MM according to the criteria of the International myeloma working group and treated at research and education hospital, were included in this study. Clinical, laboratory, pathological data were analyzed retrospectively and genetic data obtained by FISH method. RESULTS: 26 patients were female (61.9%) and 16 were male (38.1%). The mean age was 62. Del13 results were obtained in 30 of 42 patients, while positive in 6 patients (20%) negative in 24 patients (80%). Among the 30 patients with chromosome 13 results, 4 had IgA, 19 had IgG type monoclonal protein. All of the 6 patients with del13 were IgG myeloma (2 kappa, 3 lambda). DISCUSSION AND CONCLUSION: Compared to the recent studies, del13 is lower in our study. In many studies, del13 has been found in rates ranging from 30-50%. Although the rate of 20% we found is lower than the data in the literature, it is valuable in terms of reflecting the frequency of del13 in myeloma patients. Therefore, we strongly recommend that conventional karyotyping and FISH analysis of common chromosomal abnormalities be performed in newly diagnosed MM patients.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-27790multiple myelomachromosome 13 deletionfishhypodiploidy
spellingShingle Yusuf Coşkun
Güven Çetin
Mecdi Hikmet Ergüney
Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
Van Tıp Dergisi
multiple myeloma
chromosome 13 deletion
fish
hypodiploidy
title Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
title_full Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
title_fullStr Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
title_full_unstemmed Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
title_short Detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
title_sort detection of 13th chromosome deletion frequency by fluorescent in situ hybridization method in patients with multiple myeloma
topic multiple myeloma
chromosome 13 deletion
fish
hypodiploidy
url https://jag.journalagent.com/z4/download_fulltext.asp?pdir=vtd&un=VTD-27790
work_keys_str_mv AT yusufcoskun detectionof13thchromosomedeletionfrequencybyfluorescentinsituhybridizationmethodinpatientswithmultiplemyeloma
AT guvencetin detectionof13thchromosomedeletionfrequencybyfluorescentinsituhybridizationmethodinpatientswithmultiplemyeloma
AT mecdihikmeterguney detectionof13thchromosomedeletionfrequencybyfluorescentinsituhybridizationmethodinpatientswithmultiplemyeloma